2.98
price down icon0.67%   -0.02
pre-market  시장 영업 전:  2.89   -0.09   -3.02%
loading
전일 마감가:
$3.00
열려 있는:
$3
하루 거래량:
173.46K
Relative Volume:
0.48
시가총액:
$141.89M
수익:
$230.47M
순이익/손실:
$30.28M
주가수익비율:
4.8852
EPS:
0.61
순현금흐름:
$38.86M
1주 성능:
+4.20%
1개월 성능:
-5.10%
6개월 성능:
+5.30%
1년 성능:
-40.64%
1일 변동 폭
Value
$2.925
$3.0376
1주일 범위
Value
$2.86
$3.1304
52주 변동 폭
Value
$2.225
$5.26

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name
명칭
Puma Biotechnology Inc
Name
전화
(424) 248-6500
Name
주소
10880 WILSHIRE BLVD., LOS ANGELES, CA
Name
직원
185
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
PBYI's Discussions on Twitter

PBYI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PBYI
Puma Biotechnology Inc
2.98 141.89M 230.47M 30.28M 38.86M 0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-09-28 업그레이드 Citigroup Neutral → Buy
2020-06-25 재개 BofA/Merrill Underperform
2019-10-08 다운그레이드 Goldman Neutral → Sell
2019-05-10 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2019-05-10 다운그레이드 Citigroup Buy → Neutral
2019-01-17 개시 Leerink Partners Mkt Perform
2019-01-03 다운그레이드 Guggenheim Buy → Neutral
2018-11-19 업그레이드 Goldman Sell → Neutral
2018-11-02 다운그레이드 BofA/Merrill Buy → Underperform
2018-11-02 다운그레이드 JP Morgan Neutral → Underweight
2018-10-01 개시 Cantor Fitzgerald Overweight
2018-09-17 개시 Goldman Sell
2018-05-11 재확인 Stifel Buy
2017-11-10 재확인 Citigroup Buy
2017-11-10 재확인 RBC Capital Mkts Sector Perform
2017-10-02 재확인 Stifel Buy
2017-09-11 재확인 Credit Suisse Outperform
2017-07-10 재개 Leerink Partners Outperform
2017-06-06 재확인 RBC Capital Mkts Sector Perform
2017-05-25 재확인 RBC Capital Mkts Sector Perform
2017-03-02 재확인 RBC Capital Mkts Sector Perform
모두보기

Puma Biotechnology Inc 주식(PBYI)의 최신 뉴스

pulisher
Apr 28, 2025

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Yahoo

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results - BioSpace

Apr 25, 2025
pulisher
Apr 23, 2025

Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why - MSN

Apr 22, 2025
pulisher
Apr 21, 2025

Is The Options Market Predicting A Spike In Puma Biotechnology Stock? - Barchart.com

Apr 21, 2025
pulisher
Apr 21, 2025

Is the Options Market Predicting a Spike in Puma Biotechnology Stock? - Yahoo Finance

Apr 21, 2025
pulisher
Apr 11, 2025

Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential - Seeking Alpha

Apr 11, 2025
pulisher
Apr 03, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)April 2, 2025 - BioSpace

Apr 03, 2025
pulisher
Apr 02, 2025

Puma Biotech Expands Team: New Hires Receive Strategic Stock Compensation Package - Stock Titan

Apr 02, 2025
pulisher
Mar 29, 2025

Further weakness as Puma Biotechnology (NASDAQ:PBYI) drops 11% this week, taking five-year losses to 55% - simplywall.st

Mar 29, 2025
pulisher
Mar 27, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 - BioSpace

Mar 26, 2025
pulisher
Mar 26, 2025

Groundbreaking Clinical Trial: Neratinib's Novel Combination Approach Targets HER2 Tumors - Stock Titan

Mar 26, 2025
pulisher
Mar 19, 2025

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Why Investors Are Buzzing About Puma Biotechnology’s Earnings: Unpacking the Details - procarsrl.com.ar

Mar 19, 2025
pulisher
Mar 19, 2025

Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now - MSN

Mar 18, 2025
pulisher
Mar 15, 2025

10 Best Short-Term Stocks to Buy Now with Rebound Potential - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Checking in on Puma Biotechnology Inc (PBYI) after recent insiders movement - Knox Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Lowers Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St

Mar 10, 2025
pulisher
Mar 10, 2025

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Armenian Reporter

Mar 10, 2025
pulisher
Mar 08, 2025

Puma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.com - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative - Yahoo Finance

Mar 07, 2025
pulisher
Mar 06, 2025

Puma Biotech grants stock award to new hire By Investing.com - Investing.com India

Mar 06, 2025
pulisher
Mar 05, 2025

Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotech grants stock award to new hire - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Can Puma Biotechnology's Conference Presentation Signal New Growth Opportunities? - StockTitan

Mar 05, 2025
pulisher
Mar 04, 2025

Puma Biotechnology’s Earnings Call: Mixed Sentiments and Future Outlook - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Puma Biotechnology’s (PBYI) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo

Mar 02, 2025
pulisher
Feb 28, 2025

PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - sharewise

Feb 28, 2025
pulisher
Feb 27, 2025

Puma Biotechnology Reports Strong Earnings Growth in 2024 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech: Q4 Earnings Snapshot - CTPost

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Feb 27, 2025

Puma Biotechnology Inc (PBYI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Puma Biotechnology Inc 주식 (PBYI) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Ludwig Jeffrey Jerome
Chief Commercial Officer
Jan 02 '25
Sale
3.15
9,437
29,743
108,951
HUNT DOUGLAS M
See Remarks
Jan 02 '25
Sale
3.15
8,633
27,209
124,594
AUERBACH ALAN H
President and CEO
Jan 02 '25
Sale
3.15
33,841
106,657
7,029,674
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
자본화:     |  볼륨(24시간):